Bristol-Myers Squibb (BMY) reported Q4 non-GAAP earnings Thursday of $1.67 per diluted share, down from $1.70 a year earlier.
Analysts polled by FactSet expected $1.46.
Revenue for the quarter ended Dec. 31 was $12.34 billion, compared with $11.48 billion a year earlier.
Analysts polled by FactSet expected $11.57 billion.
The company said it expects 2025 adjusted EPS of $6.55 to $6.85. Analysts polled by FactSet expect $6.91.
Bristol-Myers Squibb said it expects revenue of about $45.5 billion. Analysts polled by FactSet expect $46.29 billion.
Bristol-Myers Squibb shares were down 3% in recent premarket activity Thursday.
Price: 57.94, Change: -1.77, Percent Change: -2.69
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。